Contact: Mika Ono
Scripps Research Institute
Caption: The new study illustrated an innovative technique to find structural details about G protein-coupled receptors (GPCRs), which are targeted by approximately 40 percent of modern medicines. This illustration represents a migraine, overlaid with a rendering of the human serotonin receptor (a GPCR) bound to ergotamine, an anti-migraine drug. Also shown is a rendering of a neuron network.
Credit: Image by Katya Kadyshevskaya, The Scripps Research Institute.
Usage Restrictions: None
Related news release: Team finds new way to map important drug targets